Open AccessLost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
Author(s) -
Grazia Aleppo,
Christopher G. Parkin,
Anders Carlson,
Rodolfo J. Galindo,
Davida F. Kruger,
Carol J. Levy,
Guillermo E. Umpiérrez,
Gregory P. Forlenza,
Janet B. McGill
Publication year - 2021
Publication title -
diabetes technology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.142
H-Index - 88
eISSN - 1557-8593
pISSN - 1520-9156
DOI - 10.1089/dia.2021.0196
Subject(s) - medicine , insulin pump , medicaid , diabetes mellitus , insulin , intensive care medicine , type 2 diabetes , type 1 diabetes , endocrinology , health care , economic growth , economics
Numerous studies have demonstrated the clinical value and safety of insulin pump therapy in type 1 diabetes and type 2 diabetes populations. However, the eligibility criteria for insulin pump coverage required by the Centers for Medicare & Medicaid Services (CMS) discount conclusive evidence that supports insulin pump use in diabetes populations that are currently deemed ineligible. This article discusses the limitations and inconsistencies of the insulin pump eligibility criteria relative to current scientific evidence and proposes workable solutions to address this issue and improve the safety and care of all individuals with diabetes.